Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jeay

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Endocrinology|June 21, 2001
The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the Pro-B Ba/F3 cell lineE Baixeras, S Jeay, P A Kelly, et al.
Molecular Endocrinology (Baltimore, Md.)|May 16, 2000
Growth hormone prevents apoptosis through activation of nuclear factor-kappaB in interleukin-3-dependent Ba/F3 cell lineS Jeay, G E Sonenshein, M C Postel-Vinay, et al.
Endocrinology|January 6, 2001
Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinaseS Jeay, G E Sonenshein, P A Kelly, et al.
Oncogene|October 14, 2000
Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferationM Llovera, C Pichard, S Bernichtein, et al.
Endocrinology|August 23, 2001
S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonistS Bernichtein, S Kinet, S Jeay, et al.
Endocrinology|June 29, 1999
Growth hormone (GH) and prolactin receptors in human peripheral blood mononuclear cells: relation with age and GH-binding proteinJ L Bresson, S Jeay, M C Gagnerault, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Endocrinology|June 21, 2001
The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the Pro-B Ba/F3 cell lineE Baixeras, S Jeay, P A Kelly, et al.
Molecular Endocrinology (Baltimore, Md.)|May 16, 2000
Growth hormone prevents apoptosis through activation of nuclear factor-kappaB in interleukin-3-dependent Ba/F3 cell lineS Jeay, G E Sonenshein, M C Postel-Vinay, et al.
Endocrinology|January 6, 2001
Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinaseS Jeay, G E Sonenshein, P A Kelly, et al.
Oncogene|October 14, 2000
Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferationM Llovera, C Pichard, S Bernichtein, et al.
Endocrinology|August 23, 2001
S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonistS Bernichtein, S Kinet, S Jeay, et al.
Endocrinology|June 29, 1999
Growth hormone (GH) and prolactin receptors in human peripheral blood mononuclear cells: relation with age and GH-binding proteinJ L Bresson, S Jeay, M C Gagnerault, et al.
Pageof 1